Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif

Pooja Pungaliya, Yuchen Bai, Kerri Lipinski, Vasanti S. Anand, Saurabh Sen, Eugene L. Brown, Brian Bates, Peter H. Reinhart, Andrew B. West, Warren D. Hirst, Steven P. BraithwaitePLoS 2010 · DOI

Abstract

Mutations in LRRK2 (leucine-rich repeat kinase 2) have been identified as major genetic determinants of Parkinson's disease (PD). The most prevalent mutation, G2019S, increases LRRK2's kinase activity, therefore understanding the sites and substrates that LRRK2 phosphorylates is critical to understanding its role in disease aetiology. Since the physiological substrates of this kinase are unknown, we set out to reveal potential targets of LRRK2 G2019S by identifying its favored phosphorylation motif. A non-biased screen of an oriented peptide library elucidated F/Y-x-T-x-R/K as the core dependent substrate sequence. Bioinformatic analysis of the consensus phosphorylation motif identified several novel candidate substrates that potentially function in neuronal pathophysiology. Peptides corresponding to the most PD relevant proteins were efficiently phosphorylated by LRRK2 in vitro. Interestingly, the phosphomotif was also identified within LRRK2 itself. Autophosphorylation was detected by mass spectrometry and biochemical means at the only F-x-T-x-R site (Thr 1410) within LRRK2. The relevance of this site was assessed by measuring effects of mutations on autophosphorylation, kinase activity, GTP binding, GTP hydrolysis, and LRRK2 multimerization. These studies indicate that modification of Thr1410 subtly regulates GTP hydrolysis by LRRK2, but with minimal effects on other parameters measured. Together the identification of LRRK2's phosphorylation consensus motif, and the functional consequences of its phosphorylation, provide insights into downstream LRRK2-signaling pathways.

Introduction

Leucine-Rich Repeat Kinase 2 (LRRK2) is a critical factor in the pathogenesis of Parkinson’s Disease (PD). Mutations in the LRRK2 gene, particularly the G2019S variant, represent the most frequent genetic causes of both familial and sporadic PD. While it is established that the G2019S mutation enhances the enzyme's kinase activity, the specific downstream targets (substrates) of LRRK2 remain largely elusive. Identifying these substrates is essential for mapping the signaling pathways that lead to neurodegeneration, specifically the loss of dopaminergic neurons. This study aimed to define the "molecular signature" or consensus phosphorylation motif that LRRK2 uses to recognize its targets, thereby providing a roadmap for substrate discovery.

Methods and Materials

The researchers utilized a multi-disciplinary approach to characterize LRRK2's substrate specificity:

  • Oriented Peptide Library Screening: A non-biased screen involving millions of synthetic peptide variants was conducted to determine the amino acid preferences of the G2019S mutant.
  • Bioinformatics: The identified motif was used as a query in the Scansite algorithm to search the human proteome (International Protein Index, version 3.56) for potential biological targets.
  • Mass Spectrometry (LC-MS/MS): This technique was employed to pinpoint exact phosphorylation sites, particularly during autophosphorylation events.
  • Biochemical Assays: Site-directed mutagenesis (e.g., T1410A) was used to evaluate the functional impact of specific phosphorylation sites on GTP binding, GTP hydrolysis, and protein dimerization.

Results

Identification of the Consensus Motif

The study successfully identified a core consensus motif for LRRK2 phosphorylation: F/Y-x-T-x-R/K. This signature indicates a preference for Phenylalanine (F) or Tyrosine (Y) at the P-2 position relative to the target Threonine (T), and an Arginine (R) or Lysine (K) at the P+2 position. Notably, LRRK2 showed a strong preference for Threonine over Serine, a distinct characteristic among kinases of its class.

Novel Substrate Candidates

Bioinformatic scanning revealed several high-priority candidate substrates involved in neuronal health and maintenance:

  • ATM: Involved in DNA damage repair.
  • ULK1: A key regulator of autophagy and cellular recycling.
  • MAP2: Critical for microtubule and cytoskeleton stability. In vitro assays confirmed that peptides derived from these proteins are efficiently phosphorylated by LRRK2.

Autophosphorylation and Self-Regulation

The consensus motif was also discovered within LRRK2 itself at position Thr1410, located in the Ras-of-complex (ROC) GTPase domain. Mass spectrometry confirmed that LRRK2 undergoes autophosphorylation at this site. Functional analysis of the T1410A mutant revealed a significant reduction in GTP hydrolysis activity, while kinase activity and dimerization remained largely unaffected. This suggests that Thr1410 phosphorylation acts as a subtle regulator of the enzyme's internal GTPase "clock."

Discussion

This research provides a foundational framework for understanding LRRK2 signaling by defining its preferred substrate motif. The identification of candidates like ATM and ULK1 suggests potential links between LRRK2 activity and critical cellular processes like DNA repair and autophagy. Furthermore, the discovery of autophosphorylation at Thr1410 provides insight into how LRRK2 may self-regulate its GTPase cycle.

While these findings are significant, a primary limitation is that these interactions were primarily validated in vitro. Further research is required to confirm these substrates in vivo and to determine if the subtle regulatory effects of Thr1410 phosphorylation are sufficient to drive the complex cellular cascades observed in Parkinson's disease.

Summary updated

Abstract

Mutations in LRRK2 (leucine-rich repeat kinase 2) have been identified as major genetic determinants of Parkinson's disease (PD). The most prevalent mutation, G2019S, increases LRRK2's kinase activity, therefore understanding the sites and substrates that LRRK2 phosphorylates is critical to understanding its role in disease aetiology. Since the physiological substrates of this kinase are unknown, we set out to reveal potential targets of LRRK2 G2019S by identifying its favored phosphorylation motif. A non-biased screen of an oriented peptide library elucidated F/Y-x-T-x-R/K as the core dependent substrate sequence. Bioinformatic analysis of the consensus phosphorylation motif identified several novel candidate substrates that potentially function in neuronal pathophysiology. Peptides corresponding to the most PD relevant proteins were efficiently phosphorylated by LRRK2 in vitro. Interestingly, the phosphomotif was also identified within LRRK2 itself. Autophosphorylation was detected by mass spectrometry and biochemical means at the only F-x-T-x-R site (Thr 1410) within LRRK2. The relevance of this site was assessed by measuring effects of mutations on autophosphorylation, kinase activity, GTP binding, GTP hydrolysis, and LRRK2 multimerization. These studies indicate that modification of Thr1410 subtly regulates GTP hydrolysis by LRRK2, but with minimal effects on other parameters measured. Together the identification of LRRK2's phosphorylation consensus motif, and the functional consequences of its phosphorylation, provide insights into downstream LRRK2-signaling pathways.
BibTeX
@inproceedings{pungaliya2010identification,
  author = {Pooja Pungaliya and Yuchen Bai and Kerri Lipinski and Vasanti S. Anand and Saurabh Sen and Eugene L. Brown and Brian Bates and Peter H. Reinhart and Andrew B. West and Warren D. Hirst and Steven P. Braithwaite},
  title = {{Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif}},
  booktitle = {PLoS},
  year = {2010},
  doi = {10.1371/journal.pone.0013672},
}
Figure